AstraZeneca profit up on strong sales of cancer drugs

AstraZeneca profit up on strong sales of cancer drugs

British pharmaceutical giant AstraZeneca on Thursday said net profit jumped 21 percent in the first three months of the year thanks to strong growth in sales of cancer drugs.